Compared with BTN3A3 knockdown group, BTN3A3 knockdown combined with SCH772984 treatment significantly inhibited the migration ability of ovarian cancer cells (Figures 6E, F). This evidence concerns the gene BTN3A3 and ovarian carcinoma.